US OptionsDetailed Quotes

TWST250516P55000

Watchlist

0.00
0.000.00%

15min DelayClose May 8 09:30 ET

0.00High0.00Low

Twist Bioscience Stock Discussion

Teddy123

Mar 11 19:33

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

$Twist Bioscience (TWST.US)$
Academic Breakthrough: Twist Bioscience Now Offers 4-Day Gene Synthesis at Zero Extra Cost

Analysts Notebook

Feb 13 19:50

Columns Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch

The attention of AI Medteck stocks are rapidly increasing.
Pelosi's new holdings have doubled $Tempus AI (TEM.US)$ value in just a few weeks, and $Firefly Neuroscience (AIFF.US)$'s inclusion in NVIDIA's Connect program has also caused its stock price to soar.
In addition, DeepSeek's rapid rise has boosted the AI application sector, particularly in medicine/healthcare. Cathie Wood believes medical AI is undervalued, with untapped pot...

117

285

Moomoo News Global

Feb 6 17:43

Columns AI Healthcare-tech May Be the Next Big Thing. Here's Why

US Congress member Nancy Pelosi and Ark Invest's Cathie Wood both bet big on an AI stock recently.
The stock in question is $Tempus AI (TEM.US)$, a company that uses data and artificial intelligence (AI) to create precision medicine services. ARK Invest, a prominent advocate for innovative technologies, first showed interest on December 6, when it purchased shares in this healthcare technology firm. Since that initial investment, Tempus AI h...

154

ClydePeternuts

Sep 12, 2024 15:17

Cathie Wood and Ark Invest's trade activity from today 9/10
$ARK Innovation ETF (ARKK.US)$ :
Bought $Advanced Micro Devices (AMD.US)$ $DraftKings (DKNG.US)$ $Tempus AI (TEM.US)$
Sold $Unity Software (U.US)$ $Palantir (PLTR.US)$ $Twist Bioscience (TWST.US)$ $Veracyte (VCYT.US)$
By the way..
Palantir $PLTR is on fire this year
It's up over 109% YTD, just got included in the S&P500, and today Bank of America raised their price target to $50 a share
D. E. Shaw owns almost $500 million worth of shares, more than any...

ClydePeternuts

Jul 17, 2024 16:06

Cathie Wood and Ark Invest's trade activity from 2024/07/16

Buys🟢\\ $Beam Therapeutics (BEAM.US)$ $Oklo Inc (OKLO.US)$
Sells🔴\\ $Zoom Communications (ZM.US)$ $Trimble (TRMB.US)$ $Twist Bioscience (TWST.US)$ $UiPath (PATH.US)$

frankinglily

May 14, 2024 16:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...

Moomoo AI

Jan 6, 2024 03:12

Twist Bioscience's P/S ratio remains lower due to sub-par revenue outlook, indicating investor expectation of limited future growth. Shareholder pessimism around future revenue growth contributes to this lower ratio.

Twist Bioscience Corporation (NASDAQ:TWST) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Moomoo AI

Dec 17, 2023 23:14

Twist Bioscience's optimistic cash runway and manageable burn rate are noteworthy despite the need for vigilance as the firm grows. Its market cap also points to easy fundraising potential.

Companies Like Twist Bioscience (NASDAQ:TWST) Are In A Position To Invest In Growth

Moomoo AI

Nov 12, 2023 21:08

Despite Twist Bioscience's unprofitability, rapid revenue growth indicates positive prospects. However, persistent share price decline hints at capital raising issues. Investors should assess the firm's balance sheet, market conditions and specific risks.

Shareholders in Twist Bioscience (NASDAQ:TWST) Have Lost 84%, as Stock Drops 9.6% This Past Week

Trytosaveabit

Oct 5, 2023 20:06

News

$Twist Bioscience (TWST.US)$ Twist Bioscience Announced An Antibody Discovery, Option And License Agreement With Bayer Of Up To $188M. Bayer Will Have The Option To License Antibodies Discovered Under The Collaboration

No comment yet